Monday, July 4, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

by Medical Finance
in Coronavirus
Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory
9
SHARES
103
VIEWS
Share on FacebookShare on Twitter

London Medical Laboratory warns that its testing reveals nearly one in five people still have insufficient Covid antibodies. So why has the Government scrapped the PCR tests that provide the most reliable confirmation of lateral flow results? As Omicron cases soar, it is calling on the Government not to compound its error by ending the requirement for travelers to test before arriving in the UK.

The London Medical Laboratory says scrapping many Covid testing measures because cases are so high is the equivalent of a ship’s captain stopping lookout for icebergs because there are too many.

The leading Covid-19 testing expert Dr Quinton Fivelman, PhD, Chief Scientific Officer at London Medical Laboratory, says Omicron cases in over 50s are now climbing and dumbing-down England’s Covid testing procedures at this critical time is a grave mistake.

Says Dr Fivelman: ‘On Tuesday, the UK recorded more than 200,000 coronavirus cases in a day for the first time. Our lab tests are still seeing 17% of people we check for Covid antibody levels show results lower than 50AU/ml, which is classified negative; and 2.5% have absolutely no Covid antibodies at all. That is likely to mean these people will develop more severe symptoms if they catch the virus.

‘Against this background it is surely folly to reduce testing accuracy because there are too many cases. It’s the equivalent of the Titanic’s Captain Smith not checking for icebergs because he didn’t want to change course. We shouldn’t be scrapping the requirement for more accurate PCR tests following a positive lateral flow test, largely in order to combat staff absences because people can return to work earlier by not waiting for a confirmation PCR test before isolating. PCR tests tell us much more about the spread of Omicron in communities and can identify potential new Covid-19 variants. Dumbing-down the testing regime will actually increase absences longer term.

‘The new rule only requires people to take a confirmation PCR test if they are showing symptoms. We know many people with Omicron remain asymptomatic, so fewer PCR tests will be carried out and we will have a less accurate picture of how Covid-19 is evolving in our communities.

‘Likewise, for the travel industry to be arguing that tests on travelers to the UK should be ended because cases are so much higher than they were when the measures were first introduced is topsy-turvy logic. The growth in cases is actually an argument for a more effective travel testing regime, not scrapping it. The Government must not compound the mistake it has made over PCR tests by reducing other Covid testing measures still further.

‘Scrapping the need for people to test two days before arriving in the UK will be a retrograde move that could increase UK cases at an even faster rate and potentially expose greater numbers of people to further new variants before they are detected.

‘We believe it’s probably too late for the Government to introduce any meaningful new measures to combat the exponential growth of Omicron, but what it should not have done is row back on existing Plan B measures around testing at a time when one in 25 Brits have the virus and cases are still increasing.’

If anyone is concerned about their own immune response to the jabs and how well they continue to produce antibodies, the new generation blood tests available from London Medical Laboratory are highly accurate, quick and simple to carry out, either at home through the post, or at one of the many drop-in clinics that offer this test across London and the southeast.


Dr Quinton Fivelman, PhD, Chief Scientific Officer, London Medical Laboratory

Source:

London Medical Laboratory

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Predictors of all-cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2. Image Credit: Gorodenkoff/Shutterstock

Direction and magnitude of predictors of all-cause mortality following hospitalization with influenza, RSV, or SARS-CoV-2

by Medical Finance
July 4, 2022
0

The coronavirus disease 2019 (COVID-19) pandemic, caused by the rapid outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has...

Study: A Quantum Dot Biomimetic for SARS-CoV-2 to Interrogate Dysregulation of the Neurovascular Unit Relevant to Brain Inflammation. Image Credit: Yurchanka Siarhei/Shutterstock

Quantum dot biomimetic for SARS-CoV-2 examines neurovascular dysregulation related to brain inflammation

by Medical Finance
July 4, 2022
0

In a recent study posted to the bioRxiv* pre-print server, researchers developed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus-like...

Study: Detection of a BA.1/BA.2 recombinant in travelers arriving in Hong Kong, February 2022. Image Credit: Imilian/Shutterstock

Study detects SARS-CoV-2 BA.1/BA.2 recombinant in two epidemiologically linked cases

by Medical Finance
July 4, 2022
0

Scientists have reported the continual evolution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the ongoing coronavirus...

Study: Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and Age. Image Credit: Zouls/Shutterstock

Study explores SARS-CoV-2 antibody responses in mild COVID-19 cases

by Medical Finance
July 4, 2022
0

In a recent study posted to medRxiv* preprint server, researchers evaluated antibody responses in mild cases of coronavirus disease 2019...

Study: Transcriptomic profiling of cardiac tissues from SARS-CoV-2 patients identifies DNA damage. Image Credit: Jose Luis Calvo/Shutterstock

Study generates a picture of the myocardial transcriptional landscape of COVID-19

by Medical Finance
July 4, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers profiled cardiac tissue transcriptomes of coronavirus disease 2019 (COVID-19)...

Study: SARS-CoV-2 spike variants differ in their allosteric response to linoleic acid. Image Credit: Naeblys/Shutterstock

The response of four SARS-CoV-2 spike variants to linoleic acid removal

by Medical Finance
July 4, 2022
0

A recent paper posted to the bioRxiv* preprint server depicted the differential allosteric response of the severe acute respiratory syndrome coronavirus...

Next Post
Study: 6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers. Image Credit: Flowersandtraveling / Shutterstock.com

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

Newly discovered immune cell "soldier" could be a good target for immunotherapy

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Potential effects of COVID-19 on reproductive health: a mini review. Image Credit: Rost9/Shutterstock
    Impact of COVID-19 on male and female reproductive health
  • Study: Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies. Image Credit: PHOTOCREO Michal Bednarek/Shutterstock
    Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply